Oaktree Acquisition III Life Sciences Corp（OACC）の株式分析

AI分析 of Oaktree Acquisition III Life Sciences Corp (OACC)

中立

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

バリュエーション指標

Oaktree Acquisition III Life Sciences Corp（OACC）の現在の予想PERは0.00で、5年平均は0.00です。

予想PER

大幅な割安

5年平均 P/E

0.00

現在のP/E

0.00

割高

0.00

割安

0.00

予想EV/EBITDA

大幅な割安

5年平均 EV/EBITDA

0.00

現在のEV/EBITDA

0.00

割高

0.00

割安

0.00

予想PSR

適正

5年平均 P/S

0.06

現在のP/S

0.00

割高

0.84

割安

-0.72

Alphio AI による OACC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト（25 / 50 / 25）であり、保証ではありません。

強

強気

強気 · 25%OACC

$12.28

シナリオ価格

基

基本

基本 · 50%OACC

$11.50

シナリオ価格

弱

弱気

弱気 · 25%OACC

$10.82

シナリオ価格

OACC を保有するクジラ

E

Empyrean Capital Partners, LP

+ を保有OACC

-3.81%

3か月リターン

OACC のよくある質問 — Alphio AI が回答

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.